N@N

Watson Pharmaceuticals: Watson to Present at the Sanford C. Bernstein & Co. Twenty-Fifth Annual Strategic Decisions 2009 Confer

^{Published on 2009-05-22 15:20:20, Last Modified on 2009-05-22 15:20:50 - Market Wire}
 

CORONA, CA--(Marketwire - May 22, 2009) - Watson Pharmaceuticals, Inc. (NYSE: [ WPI ]), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the Sanford C. Bernstein & Co. Twenty-Fifth Annual Strategic Decisions 2009 Conference on Wednesday, May 27, 2009 at 9:00 a.m. Eastern Daylight Time.

This presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Web site at [ http://ir.watson.com ]. The webcast can also be accessed at the following URL:

[ http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=WPI&item_id=2184558 ]

An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women's Health and Nephrology/Medical.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at [ http://www.watson.com ].